Can ibuprofen close the PDA?

Can Ibuprofen Help Close a Patent Ductus Arteriosus?

Yes, ibuprofen can effectively help close a patent ductus arteriosus (PDA), particularly in premature infants. The ductus arteriosus is a vital blood vessel during fetal development, connecting the pulmonary artery to the aorta and allowing blood to bypass the lungs. After birth, this vessel typically closes on its own. However, in some preterm babies, it remains open—a condition known as PDA—which can lead to breathing difficulties and strain on the heart.

Ibuprofen plays a key role in closing the PDA by targeting the body's production of prostaglandins, hormone-like substances that keep the ductus open. By inhibiting these prostaglandins, ibuprofen promotes the natural closure of the vessel. This mechanism is similar to that of indomethacin, another drug traditionally used for the same purpose.

What sets ibuprofen apart is its favorable safety profile. Clinical studies have shown that ibuprofen is just as effective as indomethacin in closing the PDA but with fewer side effects, especially regarding blood flow to the kidneys and the gastrointestinal tract. This makes ibuprofen a preferred option in many neonatal intensive care units.

While not every PDA requires treatment—especially if it’s small and not causing symptoms—medication like ibuprofen offers a non-surgical solution when intervention is needed. Early treatment can reduce the risk of long-term complications such as heart failure or chronic lung disease in vulnerable preterm infants.

As with any medication in neonates, timing and dosing are critical, and treatment decisions are always made carefully by a medical team. Still, ibuprofen remains a valuable tool in modern neonatology, combining effectiveness with improved tolerability for our smallest patients.